Placebo + Placebo

Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics

Effect of Ketanserin, Olanzapine, and Lorazepam After LSD Administration on the Acute Response to LSD in Healthy Subjects

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy

Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabetic peripheral neuropathy

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache

Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) once-weekly in participants with overweight or obesity

Efficacy and safety of cagrilintide s.c. in combination with semaglutide s.c. (CagriSema s.c.) once-weekly in participants with overweight or obesity and type 2 diabetes

Long-term efficacy and safety of cagrilintide s.c. 2.4 mg in combination with semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) once weekly versus placebo in participants with obesity

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease

Efficacy, safety and pharmacokinetics of cagrilintide s.c. 2.4 mg as monotherapy and in combination with semaglutide s.c. 2.4 mg (CagriSema) once weekly for weight management in children and adolescents with overweight or obesity

Scandinavian Bell's Palsy Study

Effect of Methylnaltrexone on GI Transit in Healthy Volunteers

Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

Muscle Anabolic Response to β2-adrenergic Stimulation With Increased Amino Acid Availability.